These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 7004286)

  • 1. Changes in peripheral blood T-cell rosettes in kidney allograft patients during the first postoperative month.
    Daudu P; Wright K; Geelhoed GW
    Am Surg; 1980 Dec; 46(12):697-707. PubMed ID: 7004286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total and active T cell dynamics in renal allograft recipients.
    Kerman RH; Geis WP
    Surgery; 1976 Apr; 79(4):398-407. PubMed ID: 769220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring and modulation of immune reactivity in human transplant recipients.
    Thomas F; Lee HM; Wolf JS; Mendez-Picon G; Thomas J
    Surgery; 1976 Apr; 79(4):408-13. PubMed ID: 769221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized clinical trial of antithymocyte globulin in cadaver renal allograft recipients: importance of T cell monitoring.
    Cosimi AB; Wortis HH; Delmonico FL; Russell PS
    Surgery; 1976 Aug; 80(2):155-63. PubMed ID: 781887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized clinical trial of antithymocyte globulin induction in renal transplantation comparing a fixed daily dose with dose adjustment according to T cell monitoring.
    Abouna GM; al-Abdullah IH; Kelly-Sullivan D; Kumar MS; Loose J; Phillips K; Yost S; Seirka D
    Transplantation; 1995 Jun; 59(11):1564-8. PubMed ID: 7778170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active T and EA-rosette-forming cells in human cadaver renal allograft recipients.
    Sengar DP; Rashid A; Harris JE
    Clin Exp Immunol; 1979 Feb; 35(2):236-41. PubMed ID: 373936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection.
    Khosroshahi HT; Tubbs RS; Shoja MM; Ghafari A; Noshad H; Ardalan MR
    Transplant Proc; 2008; 40(1):137-9. PubMed ID: 18261569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T and B cell patterns in irreversibly rejected human renal allografts. Correlation of morphology with surface markers and cytotoxic capacity of the isolated lymphoid infiltrates.
    Busch GJ; Schamberg JF; Moretz RC; Strom TB; Tilney NL; Carpenter CB
    Lab Invest; 1976 Sep; 35(3):272-80. PubMed ID: 785094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective monitoring and modulation of immune reactivity in allograft recipients.
    Thomas F; Lee HM; Thomas J; Mendez-Picon G
    Proc Clin Dial Transplant Forum; 1976 Nov 19-22; 6():20-6. PubMed ID: 801063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring immunosuppression following renal transplantation.
    Giorgi JV; Cosimi AB; Colvin RB; Goldstein G; Delmonico FL; Russell PS
    Diagn Immunol; 1983; 1(3):174-8. PubMed ID: 6388969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction therapy including antithymocyte globulin induces marked alterations in T lymphocyte subpopulations after liver transplantation: results of a long-term study.
    Oertel M; Sack U; Kohlhaw K; Lehmann I; Emmrich F; Berr F; Hauss J; Schwarz R
    Transpl Int; 2002 Oct; 15(9-10):463-71. PubMed ID: 12389078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat).
    Koch A; Daniel V; Dengler TJ; Schnabel PA; Hagl S; Sack FU
    J Heart Lung Transplant; 2005 Jun; 24(6):708-13. PubMed ID: 15949731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative single-bolus high-dose antithymocyte globulin as induction therapy in sensitized renal transplant recipients.
    Wang D; Wu WZ; Yang SL; Chen JH; Tan JM
    Chin Med J (Engl); 2006 Oct; 119(20):1683-8. PubMed ID: 17097014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E-rosette forming cell numbers in the blood of human renal allograft recipients.
    Kelly GE; Sheil AG
    Clin Exp Immunol; 1977 Mar; 27(3):454-63. PubMed ID: 324670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of IgG subclass levels for infectious complications in renal transplant recipients.
    Wieneke H; Otte B; Lang D; Heidenreich S
    Clin Nephrol; 1996 Jan; 45(1):22-8. PubMed ID: 8616953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-mediated immunity to donor antigens in renal allograft recipients.
    Burrows WB; Pierce JC; Hashim GA; Ramey WG; Swistel AJ; Lee DH; Fitzpatrick HF
    Surgery; 1978 Jun; 83(6):741-5. PubMed ID: 347619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring and modulation of recipient immune responsiveness to prevent kidney graft rejection in the early post-transplant period.
    Renna E; Sansonetti P; Nesci C; Famulari A; Cortesini R
    Proc Eur Dial Transplant Assoc; 1977; 14():336-41. PubMed ID: 341135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No synergy between ATG induction and costimulation blockade induced kidney allograft survival in rhesus monkeys.
    Haanstra KG; Sick EA; Ringers J; Wubben JA; Kuhn EM; 't Hart BA; Boon L; Jonker M
    Transplantation; 2006 Nov; 82(9):1194-201. PubMed ID: 17102771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [T-rosette and rosette inhibition test with antilymphocyte globulin following kidney transplantation].
    Philipp H; Scholz D; Menzel G
    Z Urol Nephrol; 1977 May; 70(5):331-8. PubMed ID: 331746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One center's experience with antithymocyte globulin treatment for acute rejection in renal transplantation.
    Colak T; Sevmiş S; Karakayali H; Moray G; Haberal M
    Transplant Proc; 2008; 40(1):123-5. PubMed ID: 18261564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.